Orgenesis Inc.
ORGS
$2.27
-$0.0525-2.26%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 899.00K | 662.00K | 529.00K | 530.00K | 13.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 899.00K | 662.00K | 529.00K | 530.00K | 13.99M |
| Cost of Revenue | 1.78M | 1.33M | 4.03M | 6.26M | 8.47M |
| Gross Profit | -878.00K | -669.00K | -3.50M | -5.73M | 5.52M |
| SG&A Expenses | 12.93M | 11.51M | 27.66M | 35.13M | 39.82M |
| Depreciation & Amortization | 728.00K | 685.00K | 667.00K | 721.00K | 793.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.82M | 21.20M | 42.07M | 52.73M | 60.46M |
| Operating Income | -25.92M | -20.54M | -41.54M | -52.20M | -46.47M |
| Income Before Tax | -35.35M | -29.45M | -51.19M | -64.45M | -58.78M |
| Income Tax Expenses | -88.00K | 274.00K | 360.00K | 473.00K | 786.00K |
| Earnings from Continuing Operations | -35.26 | -29.72 | -51.55 | -64.92 | -59.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 848.00K | 702.00K | 5.89M | 9.56M | 6.73M |
| Net Income | -34.41M | -29.02M | -45.66M | -55.36M | -52.84M |
| EBIT | -25.92M | -20.54M | -41.54M | -52.20M | -46.47M |
| EBITDA | -24.10M | -19.06M | -40.17M | -50.64M | -44.59M |
| EPS Basic | -9.38 | -8.68 | -14.04 | -19.83 | -19.23 |
| Normalized Basic EPS | -4.92 | -4.53 | -6.82 | -8.36 | -8.76 |
| EPS Diluted | -9.38 | -8.68 | -14.04 | -19.83 | -19.25 |
| Normalized Diluted EPS | -4.92 | -4.53 | -6.82 | -8.36 | -8.76 |
| Average Basic Shares Outstanding | 14.92M | 13.21M | 12.18M | 11.51M | 11.07M |
| Average Diluted Shares Outstanding | 14.92M | 13.21M | 12.18M | 11.51M | 11.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |